课题基金 / 基金详情

Targeting the mitochondria in COVID-19 pneumonia: The cardiopulmonary effects of a SARS-CoV-2 mitochondriopathy

Targeting the mitochondria in COVID-19 pneumonia: The cardiopulmonary effects of a SARS-CoV-2 mitochondriopathy
以 COVID-19 肺炎中的线粒体为靶点：SARS-CoV-2 线粒体病对心肺的影响
批准号：
464069
负责人：
Archer Stephen L
金额：
$30.76万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-03-01 至 2024-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=464069&lang=en
关键词：
Alveolar Damage Coronavirus Covid-19 Drug Discovery Experimental Therapeutics Hypoxia Hypoxic Pulmonary Vasoconstriction Mitochondria Dynamics Sars-Cov-2 Translational Medicine

项目摘要

项目成果

Archer Stephen L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
COVID-19 is an acute respiratory illness caused by SARS-CoV-2. COVID-19 has caused > 223 million infections and >4.1 million deaths. Most infected people are mildly symptomatic; however, ~5% suffer respiratory failure requiring hospitalization and 1.5% di
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Dynamin 2 expression, mitochondrial targeting, and evaluation of its role in mitochondrial fission: Implications for pulmonary arterial hypertension
The Role of Mitochondria and the NLRP3 Inflammasome in Right Ventricular Failure in Pulmonary Arterial Hypertension
Molecular identification of the oxygen sensor(s) in the fetal ductus arteriosus and pulmonary artery: an integrated multiomic comparison of mitochondria in vital fetal arteries with opposing oxygen responses
Mitochondrial Dynamics and Metabolism in Pulmonary Arterial Hypertension
海外基金